$IPXL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Impax Laboratories, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Impax Laboratories, LLC. Get notifications about new insider transactions in Impax Laboratories, LLC for free.
Page: < prev 1 2 3 4 5 6 ... 7 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 27 2016 | IPXL | IMPAX LABORATORIES ... | Nornhold Jeffrey | SVP, Technical Oper ... | Payment of Exercise | F | 21.35 | 1,694 | 36,167 | 76,453 | 78.1 K to 76.5 K (-2.17 %) |
Oct 27 2016 | IPXL | IMPAX LABORATORIES ... | Nornhold Jeffrey | SVP, Technical Oper ... | Payment of Exercise | F | 21.80 | 1,829 | 39,872 | 78,147 | 80 K to 78.1 K (-2.29 %) |
Oct 27 2016 | IPXL | IMPAX LABORATORIES ... | Reasons Bryan M. | Chief Financial Off ... | Payment of Exercise | F | 21.35 | 1,209 | 25,812 | 87,496 | 88.7 K to 87.5 K (-1.36 %) |
Aug 31 2016 | IPXL | IMPAX LABORATORIES ... | Boothe Douglas | President, Generics ... | Option Exercise | A | 24.42 | 50,500 | 1,233,210 | 50,500 | |
Aug 31 2016 | IPXL | IMPAX LABORATORIES ... | Boothe Douglas | President, Generics ... | Grant | A | 0.00 | 62,600 | 0 | 62,600 | 0 to 62.6 K |
Aug 29 2016 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Gift | G | 0.00 | 12,025 | 0 | 18,108 | 30.1 K to 18.1 K (-39.91 %) |
Aug 22 2016 | IPXL | IMPAX LABORATORIES ... | Bierly Rick | Director | Option Exercise | A | 23.35 | 11,840 | 276,464 | 11,840 | |
Aug 22 2016 | IPXL | IMPAX LABORATORIES ... | Bierly Rick | Director | Grant | A | 0.00 | 4,895 | 0 | 4,895 | 0 to 4.9 K |
Aug 17 2016 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Option Exercise | M | 6.55 | 20,000 | 131,000 | 30,000 | |
Aug 17 2016 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Sell | S | 22.81 | 10,092 | 230,199 | 30,133 | 40.2 K to 30.1 K (-25.09 %) |
Aug 17 2016 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Buy | M | 6.55 | 20,000 | 131,000 | 40,225 | 20.2 K to 40.2 K (+98.89 %) |
Aug 17 2016 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Option Exercise | M | 6.55 | 20,000 | 131,000 | 30,000 | |
Aug 17 2016 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Sell | S | 22.81 | 10,092 | 230,199 | 30,133 | 40.2 K to 30.1 K (-25.09 %) |
Aug 17 2016 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Buy | M | 6.55 | 20,000 | 131,000 | 40,225 | 20.2 K to 40.2 K (+98.89 %) |
Aug 17 2016 | IPXL | IMPAX LABORATORIES ... | NESTOR MICHAEL | President, Impax Sp ... | Sell | J | 0.00 | 24,906 | 0 | 98,190 | 123.1 K to 98.2 K (-20.23 %) |
Aug 17 2016 | IPXL | IMPAX LABORATORIES ... | NESTOR MICHAEL | President, Impax Sp ... | Sell | J | 0.00 | 24,906 | 0 | 98,190 | 123.1 K to 98.2 K (-20.23 %) |
May 24 2016 | IPXL | IMPAX LABORATORIES ... | NESTOR MICHAEL | President, Impax Ph ... | Payment of Exercise | F | 32.12 | 1,696 | 54,476 | 123,096 | 124.8 K to 123.1 K (-1.36 %) |
May 24 2016 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Payment of Exercise | F | 32.12 | 1,095 | 35,171 | 87,921 | 89 K to 87.9 K (-1.23 %) |
May 19 2016 | IPXL | IMPAX LABORATORIES ... | BURR ROBERT L | Director | Option Exercise | A | 30.33 | 10,575 | 320,740 | 10,575 | |
May 19 2016 | IPXL | IMPAX LABORATORIES ... | BURR ROBERT L | Director | Grant | A | 0.00 | 4,375 | 0 | 56,100 | 51.7 K to 56.1 K (+8.46 %) |
May 19 2016 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Option Exercise | A | 30.33 | 10,575 | 320,740 | 10,575 | |
May 19 2016 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Grant | A | 0.00 | 4,375 | 0 | 20,225 | 15.9 K to 20.2 K (+27.60 %) |
May 19 2016 | IPXL | IMPAX LABORATORIES ... | CHAO ALLEN | Director | Option Exercise | A | 30.33 | 10,575 | 320,740 | 10,575 | |
May 19 2016 | IPXL | IMPAX LABORATORIES ... | CHAO ALLEN | Director | Grant | A | 0.00 | 4,375 | 0 | 65,070 | 60.7 K to 65.1 K (+7.21 %) |
May 19 2016 | IPXL | IMPAX LABORATORIES ... | PENDERGAST MARY K | Director | Option Exercise | A | 30.33 | 10,575 | 320,740 | 10,575 | |
May 19 2016 | IPXL | IMPAX LABORATORIES ... | PENDERGAST MARY K | Director | Grant | A | 0.00 | 4,375 | 0 | 17,975 | 13.6 K to 18 K (+32.17 %) |
May 19 2016 | IPXL | IMPAX LABORATORIES ... | TERRERI PETER R | Director | Option Exercise | A | 30.33 | 10,575 | 320,740 | 10,575 | |
May 19 2016 | IPXL | IMPAX LABORATORIES ... | TERRERI PETER R | Director | Grant | A | 0.00 | 4,375 | 0 | 44,162 | 39.8 K to 44.2 K (+11.00 %) |
May 19 2016 | IPXL | IMPAX LABORATORIES ... | Vergis Janet S. | Director | Option Exercise | A | 30.33 | 10,575 | 320,740 | 10,575 | |
May 19 2016 | IPXL | IMPAX LABORATORIES ... | Vergis Janet S. | Director | Grant | A | 0.00 | 4,375 | 0 | 7,775 | 3.4 K to 7.8 K (+128.68 %) |
May 16 2016 | IPXL | IMPAX LABORATORIES ... | Reasons Bryan M. | Chief Financial Off ... | Payment of Exercise | F | 29.18 | 1,216 | 35,483 | 88,705 | 89.9 K to 88.7 K (-1.35 %) |
May 16 2016 | IPXL | IMPAX LABORATORIES ... | Reasons Bryan M. | Chief Financial Off ... | Payment of Exercise | F | 29.18 | 1,889 | 55,121 | 89,921 | 91.8 K to 89.9 K (-2.06 %) |
May 16 2016 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Payment of Exercise | F | 29.18 | 2,330 | 67,989 | 89,016 | 91.3 K to 89 K (-2.55 %) |
May 16 2016 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Payment of Exercise | F | 29.18 | 2,163 | 63,116 | 91,346 | 93.5 K to 91.3 K (-2.31 %) |
May 16 2016 | IPXL | IMPAX LABORATORIES ... | Nornhold Jeffrey | SVP, Technical Oper ... | Payment of Exercise | F | 29.18 | 337 | 9,834 | 79,976 | 80.3 K to 80 K (-0.42 %) |
May 16 2016 | IPXL | IMPAX LABORATORIES ... | NESTOR MICHAEL | President, Impax Ph ... | Payment of Exercise | F | 29.18 | 3,236 | 94,426 | 124,792 | 128 K to 124.8 K (-2.53 %) |
May 16 2016 | IPXL | IMPAX LABORATORIES ... | NESTOR MICHAEL | President, Impax Ph ... | Payment of Exercise | F | 29.18 | 3,003 | 87,628 | 128,028 | 131 K to 128 K (-2.29 %) |
May 02 2016 | IPXL | IMPAX LABORATORIES ... | Wilkinson George Fred | Chief Executive Off ... | Payment of Exercise | F | 33.35 | 61,594 | 2,054,160 | 464,862 | 526.5 K to 464.9 K (-11.70 %) |
Mar 15 2016 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Option Exercise | M | 6.55 | 3,500 | 22,925 | 50,000 | |
Mar 15 2016 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Buy | M | 6.55 | 3,500 | 22,925 | 15,850 | 12.4 K to 15.9 K (+28.34 %) |
Mar 01 2016 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Option Exercise | A | 33.27 | 52,801 | 1,756,689 | 52,801 | |
Mar 01 2016 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Grant | A | 0.00 | 21,852 | 0 | 93,509 | 71.7 K to 93.5 K (+30.50 %) |
Mar 01 2016 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Payment of Exercise | F | 33.27 | 1,931 | 64,244 | 71,657 | 73.6 K to 71.7 K (-2.62 %) |
Mar 01 2016 | IPXL | IMPAX LABORATORIES ... | Reasons Bryan M. | Chief Financial Off ... | Option Exercise | A | 33.27 | 63,095 | 2,099,171 | 63,095 | |
Mar 01 2016 | IPXL | IMPAX LABORATORIES ... | Reasons Bryan M. | Chief Financial Off ... | Grant | A | 0.00 | 26,113 | 0 | 92,845 | 66.7 K to 92.8 K (+39.13 %) |
Mar 01 2016 | IPXL | IMPAX LABORATORIES ... | Reasons Bryan M. | Chief Financial Off ... | Payment of Exercise | F | 33.27 | 1,958 | 65,143 | 66,732 | 68.7 K to 66.7 K (-2.85 %) |
Mar 01 2016 | IPXL | IMPAX LABORATORIES ... | Wilkinson George Fred | Chief Executive Off ... | Option Exercise | A | 33.27 | 215,851 | 7,181,363 | 215,851 | |
Mar 01 2016 | IPXL | IMPAX LABORATORIES ... | Wilkinson George Fred | Chief Executive Off ... | Grant | A | 0.00 | 89,332 | 0 | 526,456 | 437.1 K to 526.5 K (+20.44 %) |
Mar 01 2016 | IPXL | IMPAX LABORATORIES ... | Wilkinson George Fred | Chief Executive Off ... | Payment of Exercise | F | 33.27 | 5,567 | 185,214 | 437,124 | 442.7 K to 437.1 K (-1.26 %) |
Mar 01 2016 | IPXL | IMPAX LABORATORIES ... | NESTOR MICHAEL | President, Impax Ph ... | Option Exercise | A | 33.27 | 52,801 | 1,756,689 | 52,801 | |
Mar 01 2016 | IPXL | IMPAX LABORATORIES ... | NESTOR MICHAEL | President, Impax Ph ... | Grant | A | 0.00 | 21,852 | 0 | 131,031 | 109.2 K to 131 K (+20.01 %) |
Mar 01 2016 | IPXL | IMPAX LABORATORIES ... | NESTOR MICHAEL | President, Impax Ph ... | Payment of Exercise | F | 33.27 | 2,654 | 88,299 | 109,179 | 111.8 K to 109.2 K (-2.37 %) |
Mar 01 2016 | IPXL | IMPAX LABORATORIES ... | Nornhold Jeffrey | SVP, Technical Oper ... | Option Exercise | A | 33.27 | 41,842 | 1,392,083 | 41,842 | |
Mar 01 2016 | IPXL | IMPAX LABORATORIES ... | Nornhold Jeffrey | SVP, Technical Oper ... | Grant | A | 0.00 | 17,317 | 0 | 80,313 | 63 K to 80.3 K (+27.49 %) |
Mar 01 2016 | IPXL | IMPAX LABORATORIES ... | Nornhold Jeffrey | SVP, Technical Oper ... | Payment of Exercise | F | 33.27 | 1,204 | 40,057 | 62,996 | 64.2 K to 63 K (-1.88 %) |
Apr 14 2016 | IPXL | IMPAX LABORATORIES ... | Reasons Bryan M. | Chief Financial Off ... | Payment of Exercise | F | 35.35 | 1,035 | 36,587 | 91,810 | 92.8 K to 91.8 K (-1.11 %) |
Oct 30 2015 | IPXL | IMPAX LABORATORIES ... | Wilkinson George Fred | Chief Executive Off ... | Payment of Exercise | F | 35.75 | 16,425 | 587,194 | 442,691 | 459.1 K to 442.7 K (-3.58 %) |
Oct 30 2015 | IPXL | IMPAX LABORATORIES ... | Nornhold Jeffrey | SVP, Technical Oper ... | Payment of Exercise | F | 36.94 | 1,271 | 46,951 | 64,200 | 65.5 K to 64.2 K (-1.94 %) |
Oct 27 2015 | IPXL | IMPAX LABORATORIES ... | Nornhold Jeffrey | SVP, Technical Oper ... | Payment of Exercise | F | 35.97 | 2,349 | 84,494 | 65,471 | 67.8 K to 65.5 K (-3.46 %) |
Oct 27 2015 | IPXL | IMPAX LABORATORIES ... | Nornhold Jeffrey | SVP, Technical Oper ... | Payment of Exercise | F | 35.63 | 2,538 | 90,429 | 67,820 | 70.4 K to 67.8 K (-3.61 %) |
Oct 27 2015 | IPXL | IMPAX LABORATORIES ... | Reasons Bryan M. | Chief Financial Off ... | Payment of Exercise | F | 35.97 | 1,299 | 46,725 | 68,690 | 70 K to 68.7 K (-1.86 %) |
Oct 09 2015 | IPXL | IMPAX LABORATORIES ... | Vergis Janet S. | Director | Option Exercise | A | 38.42 | 8,100 | 311,202 | 8,100 | |
Oct 09 2015 | IPXL | IMPAX LABORATORIES ... | Vergis Janet S. | Director | Grant | A | 0.00 | 3,400 | 0 | 3,400 | 0 to 3.4 K |
Sep 14 2015 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Gift | G | 0.00 | 3,000 | 0 | 12,350 | 15.4 K to 12.4 K (-19.54 %) |
Sep 14 2015 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Gift | G | 0.00 | 850 | 0 | 15,350 | 16.2 K to 15.4 K (-5.25 %) |
Sep 14 2015 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Gift | G | 0.00 | 2,000 | 0 | 16,200 | 18.2 K to 16.2 K (-10.99 %) |
Sep 14 2015 | IPXL | IMPAX LABORATORIES ... | NESTOR MICHAEL | President, Impax Ph ... | Sell | S | 43.56 | 5,000 | 217,800 | 111,833 | 116.8 K to 111.8 K (-4.28 %) |
Sep 14 2015 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Sell | S | 43.30 | 7,457 | 322,888 | 73,588 | 81 K to 73.6 K (-9.20 %) |
Sep 02 2015 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Option Exercise | M | 6.55 | 9,000 | 58,950 | 53,500 | |
Sep 02 2015 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Buy | M | 6.55 | 9,000 | 58,950 | 18,200 | 9.2 K to 18.2 K (+97.83 %) |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Option Exercise | M | 6.55 | 2,500 | 16,375 | 53,500 | |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Option Exercise | M | 27.80 | 2,750 | 76,450 | 0 | |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Option Exercise | M | 29.03 | 2,750 | 79,833 | 0 | |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Option Exercise | M | 23.60 | 3,000 | 70,800 | 0 | |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Option Exercise | M | 25.18 | 3,000 | 75,540 | 0 | |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Option Exercise | M | 20.47 | 3,000 | 61,410 | 0 | |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Option Exercise | M | 18.09 | 3,000 | 54,270 | 0 | |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Sell | S | 40.92 | 2,500 | 102,300 | 9,200 | 11.7 K to 9.2 K (-21.37 %) |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Buy | M | 6.55 | 2,500 | 16,375 | 11,700 | 9.2 K to 11.7 K (+27.17 %) |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Sell | S | 40.92 | 2,750 | 112,530 | 9,200 | 12 K to 9.2 K (-23.01 %) |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Buy | M | 27.80 | 2,750 | 76,450 | 11,950 | 9.2 K to 12 K (+29.89 %) |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Sell | S | 40.92 | 2,750 | 112,530 | 9,200 | 12 K to 9.2 K (-23.01 %) |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Buy | M | 29.03 | 2,750 | 79,833 | 11,950 | 9.2 K to 12 K (+29.89 %) |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Sell | S | 40.92 | 3,000 | 122,760 | 9,200 | 12.2 K to 9.2 K (-24.59 %) |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Buy | M | 23.60 | 3,000 | 70,800 | 12,200 | 9.2 K to 12.2 K (+32.61 %) |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Sell | S | 40.92 | 3,000 | 122,760 | 9,200 | 12.2 K to 9.2 K (-24.59 %) |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Buy | M | 25.18 | 3,000 | 75,540 | 12,200 | 9.2 K to 12.2 K (+32.61 %) |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Sell | S | 40.92 | 3,000 | 122,760 | 9,200 | 12.2 K to 9.2 K (-24.59 %) |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Buy | M | 20.47 | 3,000 | 61,410 | 12,200 | 9.2 K to 12.2 K (+32.61 %) |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Sell | S | 40.92 | 3,000 | 122,760 | 9,200 | 12.2 K to 9.2 K (-24.59 %) |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Buy | M | 18.09 | 3,000 | 54,270 | 12,200 | 9.2 K to 12.2 K (+32.61 %) |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Option Exercise | M | 20.90 | 5,000 | 104,500 | 5,000 | |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Option Exercise | M | 17.99 | 8,000 | 143,920 | 4,000 | |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Option Exercise | M | 20.30 | 10,000 | 203,000 | 0 | |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Sell | S | 41.02 | 5,000 | 205,100 | 8,200 | 13.2 K to 8.2 K (-37.88 %) |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Buy | M | 20.90 | 5,000 | 104,500 | 13,200 | 8.2 K to 13.2 K (+60.98 %) |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Sell | S | 41.02 | 8,000 | 328,160 | 8,200 | 16.2 K to 8.2 K (-49.38 %) |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Buy | M | 17.99 | 8,000 | 143,920 | 16,200 | 8.2 K to 16.2 K (+97.56 %) |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Sell | S | 41.02 | 10,000 | 410,200 | 8,200 | 18.2 K to 8.2 K (-54.95 %) |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Buy | M | 20.30 | 10,000 | 203,000 | 18,200 | 8.2 K to 18.2 K (+121.95 %) |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Sell | S | 41.02 | 6,166 | 252,929 | 8,200 | 14.4 K to 8.2 K (-42.92 %) |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Option Exercise | M | 20.30 | 10,000 | 203,000 | 0 | |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Option Exercise | M | 20.90 | 10,000 | 209,000 | 0 | |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Option Exercise | M | 17.99 | 8,000 | 143,920 | 4,000 | |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Sell | S | 41.39 | 10,000 | 413,900 | 8,200 | 18.2 K to 8.2 K (-54.95 %) |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Buy | M | 20.30 | 10,000 | 203,000 | 18,200 | 8.2 K to 18.2 K (+121.95 %) |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Sell | S | 41.39 | 10,000 | 413,900 | 8,200 | 18.2 K to 8.2 K (-54.95 %) |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Buy | M | 20.90 | 10,000 | 209,000 | 18,200 | 8.2 K to 18.2 K (+121.95 %) |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Sell | S | 42.48 | 8,000 | 339,840 | 8,200 | 16.2 K to 8.2 K (-49.38 %) |
Sep 01 2015 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Buy | M | 17.99 | 8,000 | 143,920 | 16,200 | 8.2 K to 16.2 K (+97.56 %) |
Aug 27 2015 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Sell | S | 43.41 | 4,649 | 201,813 | 81,045 | 85.7 K to 81 K (-5.43 %) |
Aug 27 2015 | IPXL | IMPAX LABORATORIES ... | TERRERI PETER R | Director | Sell | S | 43.93 | 4,833 | 212,314 | 39,787 | 44.6 K to 39.8 K (-10.83 %) |
Aug 27 2015 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Option Exercise | M | 6.55 | 10,000 | 65,500 | 0 | |
Aug 27 2015 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Sell | S | 42.78 | 10,000 | 427,800 | 8,200 | 18.2 K to 8.2 K (-54.95 %) |
Aug 27 2015 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Buy | M | 6.55 | 10,000 | 65,500 | 18,200 | 8.2 K to 18.2 K (+121.95 %) |
Aug 27 2015 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Sell | S | 41.67 | 9,399 | 391,656 | 8,200 | 17.6 K to 8.2 K (-53.41 %) |
Jul 09 2015 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Payment of Exercise | F | 45.99 | 3,916 | 180,097 | 85,694 | 89.6 K to 85.7 K (-4.37 %) |
May 26 2015 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Payment of Exercise | F | 46.21 | 1,102 | 50,923 | 89,610 | 90.7 K to 89.6 K (-1.21 %) |
May 26 2015 | IPXL | IMPAX LABORATORIES ... | NESTOR MICHAEL | President, Impax Ph ... | Payment of Exercise | F | 46.21 | 1,696 | 78,372 | 116,833 | 118.5 K to 116.8 K (-1.43 %) |
May 19 2015 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Payment of Exercise | F | 44.44 | 2,330 | 103,545 | 90,712 | 93 K to 90.7 K (-2.50 %) |
May 19 2015 | IPXL | IMPAX LABORATORIES ... | Reasons Bryan M. | Chief Financial Off ... | Payment of Exercise | F | 44.44 | 1,391 | 61,816 | 69,989 | 71.4 K to 70 K (-1.95 %) |
May 19 2015 | IPXL | IMPAX LABORATORIES ... | SCHLOSSBERG MARK A | SVP and General Cou ... | Payment of Exercise | F | 44.82 | 2,163 | 96,946 | 93,042 | 95.2 K to 93 K (-2.27 %) |
May 19 2015 | IPXL | IMPAX LABORATORIES ... | Reasons Bryan M. | Chief Financial Off ... | Payment of Exercise | F | 44.82 | 2,161 | 96,856 | 71,380 | 73.5 K to 71.4 K (-2.94 %) |
May 18 2015 | IPXL | IMPAX LABORATORIES ... | Nornhold Jeffrey | SVP, Technical Oper ... | Payment of Exercise | F | 44.82 | 467 | 20,931 | 70,358 | 70.8 K to 70.4 K (-0.66 %) |
May 18 2015 | IPXL | IMPAX LABORATORIES ... | NESTOR MICHAEL | President, Impax Ph ... | Payment of Exercise | F | 44.44 | 3,236 | 143,808 | 118,529 | 121.8 K to 118.5 K (-2.66 %) |
May 18 2015 | IPXL | IMPAX LABORATORIES ... | NESTOR MICHAEL | President, Impax Ph ... | Payment of Exercise | F | 44.82 | 3,003 | 134,594 | 121,765 | 124.8 K to 121.8 K (-2.41 %) |
May 13 2015 | IPXL | IMPAX LABORATORIES ... | BURR ROBERT L | Director | Option Exercise | A | 44.85 | 7,300 | 327,405 | 7,300 | |
May 13 2015 | IPXL | IMPAX LABORATORIES ... | BURR ROBERT L | Director | Grant | A | 0.00 | 3,100 | 0 | 51,725 | 48.6 K to 51.7 K (+6.38 %) |
May 13 2015 | IPXL | IMPAX LABORATORIES ... | CHAO ALLEN | Director | Option Exercise | A | 44.85 | 7,300 | 327,405 | 7,300 | |
May 13 2015 | IPXL | IMPAX LABORATORIES ... | CHAO ALLEN | Director | Grant | A | 0.00 | 3,100 | 0 | 60,695 | 57.6 K to 60.7 K (+5.38 %) |
May 13 2015 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Option Exercise | A | 44.85 | 7,300 | 327,405 | 7,300 | |
May 13 2015 | IPXL | IMPAX LABORATORIES ... | FLEMING NIGEL | Director | Grant | A | 0.00 | 3,100 | 0 | 14,366 | 11.3 K to 14.4 K (+27.52 %) |
May 13 2015 | IPXL | IMPAX LABORATORIES ... | PENDERGAST MARY K | Director | Option Exercise | A | 44.85 | 7,300 | 327,405 | 7,300 | |
May 13 2015 | IPXL | IMPAX LABORATORIES ... | PENDERGAST MARY K | Director | Grant | A | 0.00 | 3,100 | 0 | 13,600 | 10.5 K to 13.6 K (+29.52 %) |
May 13 2015 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | Director | Option Exercise | A | 44.85 | 7,300 | 327,405 | 7,300 | |
May 13 2015 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | Director | Buy | Z | 0.00 | 73,560 | 0 | 2,618,860 | 2.5 M to 2.6 M (+2.89 %) |
May 13 2015 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | Director | Sell | Z | 0.00 | 73,560 | 0 | 209,337 | 282.9 K to 209.3 K (-26.00 %) |
May 13 2015 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | Director | Grant | A | 0.00 | 3,100 | 0 | 58,251 | 55.2 K to 58.3 K (+5.62 %) |
May 13 2015 | IPXL | IMPAX LABORATORIES ... | TERRERI PETER R | Director | Option Exercise | A | 44.85 | 7,300 | 327,405 | 7,300 | |
May 13 2015 | IPXL | IMPAX LABORATORIES ... | TERRERI PETER R | Director | Grant | A | 0.00 | 3,100 | 0 | 44,620 | 41.5 K to 44.6 K (+7.47 %) |
May 13 2015 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Option Exercise | A | 44.85 | 7,300 | 327,405 | 7,300 | |
May 13 2015 | IPXL | IMPAX LABORATORIES ... | MARKBREITER MICHAEL | Director | Grant | A | 0.00 | 3,100 | 0 | 17,599 | 14.5 K to 17.6 K (+21.38 %) |
May 13 2015 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Option Exercise | A | 44.85 | 12,000 | 538,200 | 12,000 | |
May 13 2015 | IPXL | IMPAX LABORATORIES ... | BENET LESLIE Z | Director | Grant | A | 0.00 | 1,100 | 0 | 9,200 | 8.1 K to 9.2 K (+13.58 %) |
May 13 2015 | IPXL | IMPAX LABORATORIES ... | NESTOR MICHAEL | President, Impax Ph ... | Payment of Exercise | F | 46.10 | 1,698 | 78,278 | 124,768 | 126.5 K to 124.8 K (-1.34 %) |
May 01 2015 | IPXL | IMPAX LABORATORIES ... | Wilkinson George Fred | Chief Executive Off ... | Payment of Exercise | F | 46.36 | 114,803 | 5,322,267 | 459,116 | 573.9 K to 459.1 K (-20.00 %) |
Apr 15 2015 | IPXL | IMPAX LABORATORIES ... | Reasons Bryan M. | Chief Financial Off ... | Payment of Exercise | F | 50.90 | 1,205 | 61,335 | 73,541 | 74.7 K to 73.5 K (-1.61 %) |
Apr 15 2015 | IPXL | IMPAX LABORATORIES ... | Nornhold Jeffrey | SVP, Technical Oper ... | Payment of Exercise | F | 51.18 | 2,384 | 122,013 | 70,825 | 73.2 K to 70.8 K (-3.26 %) |
Mar 27 2015 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | Director | Option Exercise | M | 5.06 | 23,000 | 116,380 | 0 | |
Mar 27 2015 | IPXL | IMPAX LABORATORIES ... | HSU LARRY | Director | Option Exercise | M | 11.40 | 25,000 | 285,000 | 0 |